ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AXN Aoxing Pharmaceutical Company New (delisted)

0.1218
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Aoxing Pharmaceutical Company New (delisted) AMEX:AXN AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.1218 0.00 01:00:00

SAR - Alexon Group PLC

21/03/2003 11:34am

UK Regulatory


RNS Number:0447J
Schroders PLC
21 March 2003

                                                                      FORM SAR 5

Lodge with Company Announcements Office and Newstrack, if appropriate, and the
Takeover Panel. A copy must also be sent to the company the shares of which are
being sold.

Date of disclosure:     21/03/03

      DISCLOSURE UNDER NOTE 3 ON RULE 5 OF THE RULES GOVERNING SUBSTANTIAL
                        ACQUISITIONS OF SHARES ("SARs")

Date of sale     20/03/03

Sale of          Alexon Group plc

                                   Number of shares/rights over       If rights over shares sold, as
    1)     Class of voting shares  shares sold                        opposed to the shares themselves,
    (e.g. ordinary shares)                                            specify nature of rights

Ordinary 10p shares                                319,892     shares
                                                               rights


                                    Resultant total holding of rights  Total percentage
    2)     Resultant total holding  over shares (and % of total voting
    of voting shares (and % of      shares in issue)
    total voting shares in issue)


             9,549,137 (15.518%)                               ( %)          15.518%


(3)     Party making disclosure     Schroders plc
                                                      Schroders plc on behalf of institutional clients on
        4)     (a)     Name of person selling shares  a non-beneficial basis
        or rights over shares and, if different,
        beneficial owner

             (b)     Names of any other persons
        acting by agreement or understanding


Signed, for and on behalf of the party named in (3) above

(Also print name of signatory)     Alison Dunn

Telephone and extension number     020 7658 2959 (Direct line)

                          ___________________________

For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers, Tel. No.: 020
7638 0129.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

SADFFLFLXXBXBBL

1 Year Aoxing Pharmaceutical Company New (delisted) Chart

1 Year Aoxing Pharmaceutical Company New (delisted) Chart

1 Month Aoxing Pharmaceutical Company New (delisted) Chart

1 Month Aoxing Pharmaceutical Company New (delisted) Chart